Business Standard

Human trials for Covid-19 vaccine may begin in 6 months: ICMR Official

"The virus strain isolated at the National Institute of Virology (NIV) laboratory in Pune will be used to develop the vaccine"

coronavirus, test
Premium

Kant insisted the focus should be on five per cent to 10 per cent serious patients

IANS New Delhi
As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India's top medical body has said the human trials of Covid-19 vaccine may begin at least in six months.

Speaking to IANS, Dr. Rajni Kant, Director Regional Medical Research Centre and Head at the Indian Council of Medical Research (ICMR) said, "The virus strain isolated at the National Institute of Virology (NIV) laboratory in Pune will be used to develop the vaccine, and this strain has been successfully transferred to the Bharat Biotech International Ltd. (BBIL). It is expected that the human
Topics : Coronavirus

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 26 2020 | 12:15 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com